Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock Resuscitation
NCT06568744 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2024-10-02
Summary
The goal of this multicentric randomized controlled trial is to compare, in septic shock patients who require further fluid resuscitation, two strategies of administering fluids. The intervention group will integrate fluid intolerance signals to the decision making process, while the control group will follow standard of care, for a 6 hour study protocol. The main question it aims to answer is
1. To compare the effect of both resuscitation strategies on fluid-induced harm, assessed by the change in pulmonary, cardiac, and renal function biomarkers during the study period.
2. To assess the safety of both resuscitation strategies on hypoperfusion resolution, measured by the improvement of capillary refill time (CRT) and lactate during the study period.
3. To determine the dynamics of the different fluid intolerance signals
Conditions
- Septic Shock
Interventions
- OTHER
-
Intervention resuscitation
In fluid responsive patients, fluid intolerance will be checked. Lung Ultrasound (LUS): Anterior LUS with 4-point assessment at each hemithorax. Min:0 and a max:24. Low risk: \< 10; intermediate risk: 10-14 or delta of 2 points. High risk: \>14, or an increase \>4 from baseline. VExUS: Low risk: Grade 0-1. Intermediate risk: 2. High risk: 3 E/e' ratio: Low risk: \<8. Intermediate risk: 8-13. High risk \>14. Central venous pressure (CVP): Low risk \<12 mmHg. Intermediate risk: 12-15 mmHg or a delta of 3 mmHg. High risk \> 15 mmHg or \>5 mmHg increase after a fluid challenge. In low-risk, a fluid challenge of 500 ml of balanced crystalloid will be performed in 30 minutes. If intermediate risk, a fluid challenge of 250 ml of balanced crystalloid in 30 minutes. If high-risk signals, alternative strategies (vasopressor and inodilator tests) will be deployed. After each challenge, peripheral perfusion, fluid responsiveness and intolerance will be re-assessed.
- OTHER
-
Standard of Care resuscitation
In fluid responsive patients, fluid challenges of 500 ml of balanced crystalloid will be performed in 30 minutes. After a fluid challenge, peripheral perfusion status and fluid responsiveness will be re-measured. If the patient persists with hypoperfusion, successive fluid challenges will be performed until hypoperfusion resolves or the patient becomes fluid unresponsive. If hypoperfusion signals persists and the patient becomes fluid unresponsive, alternative resuscitation interventions will be deployed, which include: 1) vasopressor titration to higher mean arterial pressure (MAP) targets in a MAP-test, and 2) addition of an inotrope to increase cardiac output in an inodilator test. If hypoperfusion fails to resolve, rescue therapies such as high-volume hemofiltration will be initiated.
Sponsors & Collaborators
-
Pontificia Universidad Catolica de Chile
lead OTHER
Principal Investigators
-
Eduardo Kattan, MD, PhD · Pontifiia Universidad Catolica de Chile
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-22
- Primary Completion
- 2026-05-31
- Completion
- 2026-07-31
Countries
- Chile
Study Locations
More Related Trials
-
Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
NCT05094856 ·Status: COMPLETED
-
Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?
NCT02116413 ·Status: COMPLETED
-
Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients
NCT06140147 ·Status: RECRUITING ·Phase: NA
-
The Effect of Rapid Fluid Challenge Under Pulmonary Artery Catheter Monitoring on Physiological Indexes of Patients With Septic Shock
NCT03661268 ·Status: UNKNOWN ·Phase: NA
-
Capillary Refill Time Response to a Rapid Fluid Challenge in Septic Shock Patients
NCT04693923 ·Status: UNKNOWN ·Phase: NA
-
The Effect of CUGP Fluid Management in Patients With Sepsis or Septic Shock
NCT06879249 ·Status: COMPLETED ·Phase: NA
-
Fluid Responseveness in Sepsis and Its Correlation to CVP
NCT05612529 ·Status: TERMINATED
-
Evolution of Tissue Perfusion and Venous Congestion Markers in Fluid-Responsive Septic Shock Patients
NCT06958809 ·Status: NOT_YET_RECRUITING
-
Assessment of Fluid Responsiveness in Septic Shock Patients, Can End-tidal co2 Measurement Help?
NCT05557461 ·Status: UNKNOWN
-
Thoracic Fluid Content During Stabilization and Therapeutic De-escalation in Septic Shock
NCT06572995 ·Status: RECRUITING
-
Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study
NCT03078712 ·Status: COMPLETED ·Phase: NA
-
Timing of Preload Responsiveness in Sepsis
NCT05627817 ·Status: UNKNOWN
-
Survey of Non-resuscitation Fluids in Septic Shock
NCT03438097 ·Status: COMPLETED
-
OPTImized Restrictive Strategy Targeting Non-Resuscitative FLUIDs in Septic Shock: Pilot Study.
NCT04947904 ·Status: COMPLETED ·Phase: NA
-
Protocolized Reduction of Non-resuscitation Fluids vs Usual Care in Septic Shock Feasibility Trial
NCT05249088 ·Status: COMPLETED ·Phase: NA
-
Temporal Changes of Lactate in CLASSIC Patients
NCT05629780 ·Status: COMPLETED ·Phase: NA
-
Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock
NCT03461900 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2
NCT06062303 ·Status: RECRUITING ·Phase: NA
-
Interstitial Fluid Composition in Patients With Septic Versus Non-septic Shock: an Exploratory Pilot Study
NCT05039151 ·Status: COMPLETED
-
Evaluation of Fluid Resuscitation in Children With Cancer With Severe Sepsis / Septic Shock
NCT01304680 ·Status: UNKNOWN
-
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 ·Status: UNKNOWN ·Phase: NA
-
Effect of Vasopressin on Kidney and Cardiac Function in Septic Shock
NCT06125184 ·Status: RECRUITING ·Phase: NA
-
The Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Trial
NCT03668236 ·Status: COMPLETED ·Phase: PHASE4
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Monitoring Resuscitation in Severe Sepsis and Septic Shock
NCT01747057 ·Status: UNKNOWN ·Phase: NA